UNKNOWN COOL TIP ELECRTRODE
Report
- Report Number
- 1717344-2019-01561
- Event Type
- Malfunction
- Date Received
- November 27, 2019
- Date of Event
- May 28, 2018
- Report Date
- November 27, 2019
- Manufacturer
- COVIDIEN MFG DC BOULDER
- Product Code
- GEI
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TW
- Reporter Occupation
- OTHER
Narratives
(B)(4). TITLE: PROGNOSTIC FACTORS OF RADIOFREQUENCY ABLATION THERAPY FOR LIVER METASTASES FROM COLORECTAL CANCER SOURCE: ADVANCES IN DIGESTIVE MEDICINE. ADV DIG MED. 2019;6:101¿108; RECEIVED: 20 AUGUST 2017, ACCEPTED: 28 MAY 2018. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
ACCORDING TO THE LITERATURE SOURCE, THE PROGNOSTIC FACTORS IN PATIENTS WITH COLORECTAL LIVER METASTASES UNDERGOING RADIOFREQUENCY ABLATION (RFA). BETWEEN 2008 AND 2013, 52 PATIENTS (MALES 34, FEMALE 18 MEAN AGE: 63 YEARS) WITH COLORECTAL LIVER METASTASES TREATED WITH EITHER PERCUTANEOUS RFA (N = 33) OR INTRAOPERATIVE RFA PLUS RESECTION (N = 19) WERE ENROLLED. THE COOL-TIP RADIOFREQUENCY SYSTEM (RADIONICS, (B)(4)V) WAS USED UNDER REAL-TIME ULTRASONOGRAPHIC GUIDANCE USING A 17-GAUGE, 2 OR 3-CM, COOLED-TIP ELECTRODE CONNECTED TO A GENERATOR. TO AVOID A RAPID INCREASE IN INTRATUMORAL PRESSURE, RFA WAS STARTED AT A LOW POWER (60 W), AND POWER WAS INCREASED IN INCREMENTS OF 10 W/MIN. AUTHORS NOTED ¿PRIMARY TECHNICAL SUCCESS WAS ACHIEVED IN 45 (87%) OF THE CASES; 7 CASES HAD FAILURES. THE MAJOR COMPLICATIONS INCLUDED THE FORMATION OF ONE HEPATIC ABSCESSES WITHOUT DRAINAGE AND ONE TRANSIENT HEPATIC DECOMPENSATION WITH JAUNDICE AND ASCITES. THE RATE OF MAJOR COMPLICATION WAS 3.8%. THERE WERE NO PROCEDURE-RELATED DEATHS. ARTICLE: CHUN-HSIEN CHEN, 2019, WILEY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1181740 | UNKNOWN COOL TIP ELECRTRODE | ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES | GEI | COVIDIEN MFG DC BOULDER | UNKNOWN COOL TIP ELECRTRODE |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 63 YR |